Evidence map›Paper›PMID 42391226›Full record

ArticlePLoS neglected tropical diseases2026

Hantavirus stability and inactivation.

Léna Vandenabeele, Abraham Ayanwale, Thomas Pietschmann, Benjamin Erik Nilsson-Payant

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Léna VandenabeeleDivision of Virology and Immunology, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Abraham AyanwaleInstitute for Experimental Virology, TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Hannover, Germany.
Thomas PietschmannInstitute for Experimental Virology, TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Hannover, Germany.
Benjamin Erik Nilsson-PayantDivision of Virology and Immunology, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-2661-7837

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hantaviruses are zoonotic viruses that can cause highly pathogenic disease, including hantavirus cardiopulmonary syndrome (HCPS) and haemorrhagic fever with renal syndrome (HFRS), in humans with case-fatality rates of up to 50%. However, our understanding of the basic viral life cycle and the underlying causes of viral pathogenesis remains sparse, in large part due to a lack of molecular biology tools for hantaviruses and the need to work in high-containment laboratory facilities with these viruses. The stability and inactivation of hantavirus particles has been examined in some limited previous studies, however, a comprehensive, detailed and robust investigation of the stability of multiple hantaviruses has not been performed yet. Here, we investigated the kinetics of infectious Tula virus (TULV) particle production in Vero E6 cells and subsequent stability in cell culture media. In addition, we evaluated the stability of infectious virus particles in response to different physical and environmental stresses, including heat, freezing, dehydration and UV exposure, answering key questions about the environmental transmission potential of hantaviruses. Interestingly, we observed a remarkable stability of TULV when stored at room temperature or colder, as well as after dehydration, which suggests that hantaviruses could remain infectious for a sustained period of time after being secreted by their host species. Subsequently, we determined the ability of commonly used virus inactivation methods, including RNA and protein extraction buffers, to inactivate TULV both in a cell-free and cell-associated context and found that TULV was efficiently inactivated by all these methods similar to other enveloped RNA viruses. Finally, we successfully validated the complete inactivation using these inactivation methods using the highly pathogenic HCPS-causing New World Andes virus (ANDV) and the HFRS-causing Old World Hantaan virus (HTNV). These results provide valuable information about safe and effective inactivation methods of viral samples and about the environmental risk potential of hantaviruses.

Indexed as

Microbial ViabilityOrthohantavirusVirus InactivationAnimalsChlorocebus aethiopsHot TemperatureHumansUltraviolet RaysVero Cells

Identifiers

PMID42391226
PMCPMC13354083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.